Pharmaceutical - LCP-Tacro

Filter

Current filters:

LCP-Tacro

Popular Filters

6751 to 6775 of 6816 results

New study reveals risks with Roche’s Avastin for wet AMD versus Lucentis

05-05-2011

A new Medicare analysis conducted by Johns Hopkins University in the USA was presented yesterday at the…

AvastinLucentisNovartisOphthalmicsPharmaceuticalResearchRoche

Bayer would consider “merger of equals” for its health care unit, CEO tells Bloomberg

05-05-2011

Although German drugs and crop sciences major Bayer AG (BAY: DE) is fine with doing nothing, a “merger…

BayerMergers & AcquisitionsPharmaceutical

293 new drugs await regulatory approval in Turkey

05-05-2011

A survey of 33 companies from the research-based pharmaceutical industry in Turkey found that the number…

EuropePharmaceuticalRegulation

Cephalon 1st-qtr 2011 sales leap 28% but below consensus forecasts

05-05-2011

US drugmaker Cephalon (Nasdaq: CEPH), which earlier this week agreed to be acquired by Israel’s…

CephalonFinancialPharmaceutical

Ipsen reports strong drug sales for first quarter 2011

05-05-2011

French drugmaker Ipsen (Euronext: IPN) reported a 6.1% increase in sales to 285.8 million euros ($423.2…

FinancialIpsenPharmaceutical

Non-Hodgkins lymphoma drug market set to more than double by 2019

05-05-2011

Driven by the launches of premium-priced therapies, the non-Hodgkin’s lymphoma drug market will…

ArzerraGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalRituxanrituximabRoche

USA’s FDA and FTC act to remove fraudulent STD products from the market

05-05-2011

The US Food and Drug Administration has joined forces with the Federal Trade Commission in a joint effort…

North AmericaPharmaceuticalRegulationReproductive

US shortages of key drugs are endangering patients

04-05-2011

In the USA, doctors, hospitals and federal regulators are struggling to cope with an unprecedented surge…

Markets & MarketingNorth AmericaPharmaceutical

Pfizer 1st-qtr 2011 beats forecasts, as profits rise 10%

04-05-2011

Pfizer (NYSE: PFE), the world’s largest pharmaceutical company by sales, beat analysts’ consensus…

FinancialPfizerPharmaceutical

US FDA clears Boehringer and Lilly’s diabetes drug Tradjenta

04-05-2011

The US Food and Drug Administration has approved Tradjenta (linagliptin), for use along with diet and…

Boehringer IngelheimDiabetesEli LillylinagliptinNorth AmericaPharmaceuticalRegulationTradjenta

Swiss IVAL Pharma to invest $150 million in Uzbekistan plant to make insulin and other products

04-05-2011

Switzerland-based IVAL Pharma AG is considering investing up to $150 million in the construction of a…

DiabetesEuropeFinancialIVAL PharmaMarkets & MarketingPharmaceutical

Astellas recruits Big Pharma execs to strengthen US global development team

04-05-2011

Astellas Pharma Global Development (APGD), a subsidiary of Japanese drug major Astellas Pharma (TSE:…

Astellas PharmaManagementPharmaceutical

Merck & Co 1st-qtr 2011 profits triple, beating analysts’ forecasts

03-05-2011

US drugs giant Merck & Co (NYSE: MRK) posted a first-quarter 2011 profit of $1.04 billion, compared with…

FinancialMerck & CoPharmaceutical

Bristol-Myers Squibb sees 1st-qtr 2011 profit jump 33%; key R&D milestones

03-05-2011

US drug major Bristol-Myers Squibb Company (NYSE: BMY) last Thursday announced first quarter 2011 results…

Bristol-Myers SquibbFinancialPharmaceutical

Australian Health Minister will not reverse PBS drug listing decision

03-05-2011

Australia’s Federal Health Minister, Nicola Roxon has refused to back down from the government's…

Asia-PacificPharmaceuticalPoliticsPricing

Nycomed may invest 35 million euros in Ukrainian production capacities

03-05-2011

Independent Swiss drugmaker Nycomed is considering establishing its own high-tech production in Ukraine,…

EuropeFinancialMarkets & MarketingNycomedPharmaceutical

Johnson & Johnson unit voluntarily withdraws NDA for trabectedin

03-05-2011

Centocor Ortho Biotech Products, a division of US health care giant Johnson & Johnson (NYSE: JNJ), says…

Centocor Ortho BiotechJohnson & JohnsonNorth AmericaOncologyPharmaceuticalRegulationtrabectedinYondelisZeltia

Grifols closer to Talecris acquisition, but must sell assets

03-05-2011

Spanish health care group Grifols (GRLS: MC) and acquisition target Talecris Biotherapeutics (Nasdaq:…

GrifolsMergers & AcquisitionsPharmaceuticalTalecris

“Innovation - is it Science or Art?”

03-05-2011

Innovation is mainly a product of creativity but can it be measured scientifically and therefore improved?…

ManagementPharmaceuticalResearch

6751 to 6775 of 6816 results

Back to top